Hepatitis B Virus Reactivation in Kidney Transplant Recipients Treated With Belatacept

INTRODUCTION: Hepatitis B virus (HBV) reactivation in kidney transplant recipients has been reported in 3% to 9% of anti-HBc antibody (HBcAb)-positive HBs antigen (HBsAg)-negative patients. It has not been studied in patients receiving belatacept, a selective costimulation blocker. METHODS: We perfo...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwarz, Chloë, Morel, Antoine, Matignon, Marie, Grimbert, Philippe, Rondeau, Eric, Ouali, Nacera, François, Hélène, Mesnard, Laurent, Petit-Hoang, Camille, Rafat, Cédric, Dahan, Karine, Luque, Yosu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403656/
https://www.ncbi.nlm.nih.gov/pubmed/37547512
http://dx.doi.org/10.1016/j.ekir.2023.05.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403656/
https://www.ncbi.nlm.nih.gov/pubmed/37547512
http://dx.doi.org/10.1016/j.ekir.2023.05.005

Ejemplares similares